SCHEMBL14867412

SCHEMBL14867412

CCCC(=O)C1C(=O)CC(c2ccco2)CC1=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 7/20 0.53
MAPT P10636 6/20 0.53
TDP1 Q9NUW8 5/20 0.53
KMT2A Q03164 5/20 0.53
NPSR1 Q6W5P4 2/20 0.53
L3MBTL1 Q9Y468 6/20 0.50
RECQL P46063 3/20 0.50
APOBEC3A P31941 1/20 0.50
APOBEC3G Q9HC16 1/20 0.50
ALDH1A1 P00352 10/20 0.47
HTT P42858 3/20 0.47
ADORA2B P29275 2/20 0.46
GAA P10253 3/20 0.44
MAPK1 P28482 2/20 0.44
ALOX15 P16050 3/20 0.44
HSD17B10 Q99714 3/20 0.44
KDM4E B2RXH2 3/20 0.44
MEN1 O00255 3/20 0.43
LMNA P02545 2/20 0.43
PKM P14618 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12648261 0.90 POLB (0.54) POLBMAPTTDP1KMT2ANPSR1
SCHEMBL1782631 0.81 POLB (0.56) POLBMAPTTDP1KMT2ANPSR1
SCHEMBL11162120 0.79 MAPT (0.46) POLBMAPTTDP1KMT2ANPSR1
SCHEMBL12648392 0.77 POLB (0.52) POLBMAPTTDP1KMT2ANPSR1
SCHEMBL11169421 0.76 POLB (0.55) POLBMAPTTDP1KMT2ANPSR1
SCHEMBL11158070 0.76 ALDH1A1 (0.46) POLBMAPTTDP1KMT2ANPSR1
SCHEMBL11170381 0.76 POLB (0.45) POLBMAPTTDP1KMT2ANPSR1
SCHEMBL10628040 0.76 LMNA (0.48) ALDH1A1HSD17B10KDM4ELMNA
SCHEMBL14867405 0.75 POLB (0.54) POLBMAPTTDP1KMT2ANPSR1
SCHEMBL11155734 0.75 ALDH1A1 (0.46) POLBMAPTTDP1KMT2ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8846747-B2 Compounds and methods for altering lifespan of eukaryotic organisms UNIVERSITY OF ROCHESTER (US) 2014-09-30 US claimed
US-8846747-B2 Compounds and methods for altering lifespan of eukaryotic organisms UNIVERSITY OF ROCHESTER (US) 2014-09-30 US disclosed
US-8846747-B2 Compounds and methods for altering lifespan of eukaryotic organisms UNIVERSITY OF ROCHESTER (US) 2014-09-30 US disclosed
US-20130096175-A1 Compounds and Methods for Altering Lifespan of Eukaryotic Organisms SOUTHERN RESEARCH INSTITUTE (US) 2013-04-18 US disclosed
US-20130096175-A1 Compounds and Methods for Altering Lifespan of Eukaryotic Organisms SOUTHERN RESEARCH INSTITUTE (US) 2013-04-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130096175-A1 Compounds and Methods for Altering Lifespan of Eukaryotic Organisms HDAC5, AADAC, SIRT1 POLB 2377/4885MAPT 2167/4885TDP1 1113/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.